| Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer’s disease A Nobili, EC Latagliata, MT Viscomi, V Cavallucci, D Cutuli, G Giacovazzo, ... Nature communications 8 (1), 14727, 2017 | 415 | 2017 |
| Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design R Coccurello, A Moles Pharmacology & therapeutics 127 (3), 210-251, 2010 | 210 | 2010 |
| Impact of dietary fats on brain functions R Chianese, R Coccurello, A Viggiano, M Scafuro, M Fiore, G Coppola, ... Current neuropharmacology 16 (7), 1059-1085, 2018 | 154 | 2018 |
| Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats R Coccurello, N Breysse, M Amalric Neuropsychopharmacology 29 (8), 1451-1461, 2004 | 144 | 2004 |
| Psychosocial stress affects energy balance in mice: modulation by social status A Moles, A Bartolomucci, L Garbugino, R Conti, A Caprioli, R Coccurello, ... Psychoneuroendocrinology 31 (5), 623-633, 2006 | 133 | 2006 |
| Hedonic eating and the “delicious circle”: from lipid-derived mediators to brain dopamine and back R Coccurello, M Maccarrone Frontiers in neuroscience 12, 271, 2018 | 130 | 2018 |
| Chronic social stress, hedonism and vulnerability to obesity: lessons from rodents R Coccurello, FR D’Amato, A Moles Neuroscience & Biobehavioral Reviews 33 (4), 537-550, 2009 | 110 | 2009 |
| Satiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intake G Provensi, R Coccurello, H Umehara, L Munari, G Giacovazzo, ... Proceedings of the National Academy of Sciences 111 (31), 11527-11532, 2014 | 104 | 2014 |
| The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum A Pintor, MT Tebano, A Martire, R Grieco, M Galluzzo, ML Scattoni, ... Neuropharmacology 51 (5), 1004-1012, 2006 | 99 | 2006 |
| NGF and BDNF alterations by prenatal alcohol exposure V Carito, M Ceccanti, G Ferraguti, R Coccurello, S Ciafrè, P Tirassa, ... Current neuropharmacology 17 (4), 308-317, 2019 | 89 | 2019 |
| Unstable Maternal Environment, Separation Anxiety, and Heightened CO2 Sensitivity Induced by Gene-by-Environment Interplay FR D'Amato, C Zanettini, V Lampis, R Coccurello, T Pascucci, R Ventura, ... PLoS One 6 (4), e18637, 2011 | 89 | 2011 |
| Paternal alcohol exposure in mice alters brain NGF and BDNF and increases ethanol‐elicited preference in male offspring M Ceccanti, R Coccurello, V Carito, S Ciafrè, G Ferraguti, G Giacovazzo, ... Addiction biology 21 (4), 776-787, 2016 | 86 | 2016 |
| A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2‐arachidonoylglycerol with potential anti‐obesity effects T Bisogno, A Mahadevan, R Coccurello, JW Chang, M Allarà, Y Chen, ... British journal of pharmacology 169 (4), 784-793, 2013 | 81 | 2013 |
| Nucleus accumbens dopamine receptors in the consolidation of spatial memory A Mele, M Avena, P Roullet, E De Leonibus, S Mandillo, F Sargolini, ... Behavioural pharmacology 15 (5), 423-431, 2004 | 76 | 2004 |
| The novel reversible fatty acid amide hydrolase inhibitor ST4070 increases endocannabinoid brain levels and counteracts neuropathic pain in different animal models A Caprioli, R Coccurello, C Rapino, S Di Serio, M Di Tommaso, ... Journal of Pharmacology and Experimental Therapeutics 342 (1), 188-195, 2012 | 74 | 2012 |
| What is “Hyper” in the ALS Hypermetabolism? A Ferri, R Coccurello Mediators of inflammation 2017 (1), 7821672, 2017 | 73 | 2017 |
| Anhedonia in depression symptomatology: Appetite dysregulation and defective brain reward processing R Coccurello Behavioural Brain Research 372, 112041, 2019 | 71 | 2019 |
| Postnatal aversive experience impairs sensitivity to natural rewards and increases susceptibility to negative events in adult life R Ventura, R Coccurello, D Andolina, EC Latagliata, C Zanettini, ... Cerebral cortex 23 (7), 1606-1617, 2013 | 65 | 2013 |
| Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects R Coccurello, A Caprioli, O Ghirardi, R Conti, B Ciani, S Daniele, ... Psychopharmacology 186, 561-571, 2006 | 64 | 2006 |
| Skeletal-muscle metabolic reprogramming in ALS-SOD1G93A mice predates disease onset and is a promising therapeutic target S Scaricamazza, I Salvatori, G Giacovazzo, JP Loeffler, F Renè, M Rosina, ... IScience 23 (5), 2020 | 58 | 2020 |
